Rubella screening

	Rubella Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Rubella from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Case Studies
Case #1
Rubella screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Rubella screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Rubella screening
CDC on Rubella screening
Rubella screening in the news
Blogs on Rubella screening
Directions to Hospitals Treating Rubella
Risk calculators and risk factors for Rubella screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S., Aravind Kuchkuntla, M.B.B.S [2]

Overview[edit | edit source]

There are no standard screening test recommended for rubella infection, however pregnant women with suspected rubella infection must be investigated to confirm the diagnosis to prevent fetal anomalies.^[1]

Screening[edit | edit source]

There is no screening test for rubella, however, if there is a high clinical suspicion of rubella infection during pregnancy, serum IgG and IgM antibodies against rubella may be ordered. Also, if a pregnant woman proves to be not immune aganist rubella, vaccination with MMR should be deferred till after delivery due to the theoretical teratogenic effects of the rubella vaccine.^[2]^[3]^[4]

References[edit | edit source]

↑ Gerace TM (1987). "Rubella screening and immunization: its history and future-an ongoing challenge". Can Fam Physician. 33: 111–5. PMC 2218305. PMID 21267342.
↑ U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.
↑ Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.
↑ Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P (2017). "Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis". J Med Virol. doi:10.1002/jmv.24818. PMID 28370103.

Template:WH Template:WS

[pmid21267342-1] Gerace TM (1987). "Rubella screening and immunization: its history and future-an ongoing challenge". Can Fam Physician. 33: 111–5. PMC 2218305. PMID 21267342.

[USPSTF-2] U.S. Preventive Services Task Force https://www.uspreventiveservicestaskforce.org/BrowseRec/Search?s=congenital+rubella+syndrome. Accessed on Jan 17, 2017.

[CDC-3] Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Accessed on Jan 17, 2017.

[pmid28370103-4] Snell LB, Smith C, Chaytor S, McRae K, Patel M, Griffiths P (2017). "Screening for potential susceptibility to rubella in an antenatal population: A multivariate analysis". J Med Virol. doi:10.1002/jmv.24818. PMID 28370103.

[1]

[2]

[3]

[4]